Program Description
Precision medicine has fundamentally altered the management of non-small cell
lung cancer (NSCLC), which accounts for approximately 85% of all lung cancer
diagnoses and remains a leading cause of cancer-related mortality. Biomarker
testing is critical in NSCLC because it identifies specific genetic alterations
that allow for the selection of targeted therapies, which have been shown to
significantly improve progression-free survival and reduce systemic toxicity
compared with traditional chemotherapy. Given the significant treatment burden
and the complexity of the therapeutic landscape, identifying targetable genomic
alterations is now becoming standard in NSCLC treatment and management plans.
This session reviews the pharmacist’s role in navigating biomarker testing in
NSCLC, from initial sample acquisition to the application of targeted
therapies. Faculty experts will examine current guideline recommendations for
mutational and genomic testing and address practical testing pearls, such as
tissue requirements, turnaround times, and the logistics of coordination.
Strategies for interpreting complex genomic reports using evidence-based
resources will also be outlined. By reviewing institutional models and
pharmacist-led interventions, including participation in molecular tumor boards
and the utilization of EMR-based clinical decision support tools, oncology
pharmacists will gain insights into overcoming common implementation barriers
affecting practice.
Target audience: Oncology pharmacists
Type of activity: Application
Release date: May 12, 2026
Expiration date: May 12, 2027
Learner level: Foundational, Intermediate
Time to complete activity: .75 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain current guideline recommendations for biomarker, mutational, and genomic testing in non-small cell lung cancer (NSCLC)
- Identify the advancing role of pharmacists in supporting personalized care through biomarker testing and targeted therapeutic strategies
- Document best practices that have optimized biomarker testing workflows in NSCLC
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here